Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes

Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter

(2011) Carlos E de Andrea et al.   JOURNAL OF PATHOLOGY

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

(2011) M Fernanda Amary et al.   JOURNAL OF PATHOLOGY

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

(2011) Twinkal C Pansuriya et al.   NATURE GENETICS

Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT

(2011) C E de Andrea et al.   ONCOGENE

Genome-wide analysis of Ollier disease: Is it all in the genes?

(2011) Twinkal C Pansuriya et al.   Orphanet Journal of Rare Diseases

No Haploinsufficiency but Loss of Heterozygosity for EXT in Multiple Osteochondromas

(2010) Christianne M.A. Reijnders et al.   AMERICAN JOURNAL OF PATHOLOGY

Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer

(2010) Péter Tátrai et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Disaccharide Composition of Heparan Sulfates: Brain, Nervous Tissue Storage Organelles, Kidney, and Lung

(2010) H. Tekotte et al.   JOURNAL OF NEUROCHEMISTRY

Aberrant Heparan Sulfate Proteoglycan Localization, Despite Normal Exostosin, in Central Chondrosarcoma

(2009) Yvonne M. Schrage et al.   AMERICAN JOURNAL OF PATHOLOGY

Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis

(2009) H Lemjabbar-Alaoui et al.   ONCOGENE

Heparan sulfate proteoglycans: A GAGgle of skeletal-hematopoietic regulators

(2008) Kathryn D. Rodgers et al.   DEVELOPMENTAL DYNAMICS